<DOC>
	<DOCNO>NCT02559817</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy linaclotide treatment Irritable Bowel syndrome Constipation ( IBS-C ) , child age 7-17 year . This study include 4-week Screening Period , 2 3-week Pretreatment Period . Patients age 7-11 receive oral liquid oral solid capsule patient 12-17 receive solid oral capsule formulation . Children age 7-11 year meet entry criterion randomize 1 3 dos linaclotide placebo 4 week . Children age 12-17 year meet entry criterion randomize 1 4 dos linaclotide placebo 4 week . This 4-week study ass effect linaclotide bowel movement frequency , well bowel symptom IBS-C .</brief_summary>
	<brief_title>A Safety Efficacy Study Range Linaclotide Doses Administered Orally Children Ages 7-17 Years , With Irritable Bowel Syndrome With Constipation</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Patient weigh least 18 kg ( 39.7 lb ) Patient meet Rome III criterion child/adolescent IBS : least per week least 2 month Screening Visit , patient experience abdominal discomfort ( uncomfortable sensation describe pain ) pain associate 2 follow least 25 % time : 1 . Improvement defecation 2 . Onset associate change frequency stool 3 . Onset associate change form ( appearance ) stool Patient meet modify Rome III criterion child/adolescent Functional Constipation ( FC ) : For least 2 month Screening Visit , patient 2 few defecation ( defecation occur absence laxative , suppository , enema use precede 24 hour ) toilet per week . In addition , least per week , patient meet 1 follow : 1 . History retentive posturing excessive volitional stool retention 2 . History painful hard bowel movement ( BMs ) 3 . Presence large fecal mass rectum 4 . History large diameter stool may obstruct toilet Patient willing discontinue laxative use Pretreatment Visit favor protocolpermitted rescue medicine Patient average few 3 spontaneous BMs ( SBMs ) per week 14 day randomization day randomization . An SBM define BM occur absence laxative , enema , suppository use calendar day BM calendar day BM Patient parent/guardian/LAR caregiver compliant eDiary complete morning evening assessment 10 14 day immediately precede Randomization Visit Patient report 1 loose , mushy stool ( eDiaryrecorded stool consistency 6 Pediatric Bristol Stool Form Scale [ pBSFS ] ) watery stool ( eDiaryrecorded stool consistency 7 pBSFS ) SBM occur absence laxative use calendar day BM calendar day BM 14 day randomization day randomization Select medical history condition may relate cause constipation may interfere safety efficacy analyse Patient require manual hospitalbased disimpaction time prior randomization Patient unable tolerate placebo rhe Screening Period</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Irritable Bowel Syndrome Constipation child</keyword>
	<keyword>Linzess</keyword>
</DOC>